Blood-brain barrier dysfunction and altered choroid plexus contrast kinetics in Parkinson’s disease

Abstract Background Neurovascular dysfunction may contribute to Parkinson’s disease (PD), but the extent and clinical relevance of blood-brain barrier alterations remain uncertain. We investigated regional blood-brain barrier permeability, fractional plasma volume, and choroid plexus contrast kinetics in patients with PD using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Methods In this exploratory cross-sectional study, 14 patients with PD and nine age-matched controls underwent 3-T DCE-MRI. The transfer constant (K trans ), fractional plasma volume (v p ), and normalized permeability index (NPI), a measure sensitive to slow contrast accumulation, were quantified in predefined cortical, subcortical, white matter, midbrain, and choroid plexus regions. Group differences and, within the PD group, associations with disease duration, levodopa equivalent daily dose (LEDD), disease severity, motor symptom laterality and Montreal Cognitive Assessment (MoCA) score were assessed. Results Compared with controls, participants with PD demonstrated higher K trans and NPI and lower v p across multiple regions, including the basal ganglia, thalamus, hippocampus, midbrain, cerebral cortex, and white matter. Voxel-wise analyses supported the regional findings, showing increased permeability predominantly in the frontal cortex and widespread reductions in v p . In exploratory within-PD analyses, longer disease duration was associated with higher NPI, whereas higher levodopa equivalent daily dose was associated with lower v p . In an exploratory analysis of seven patients with unilateral onset, NPI was higher in the hemisphere contralateral to the clinically affected body side. Within the PD group, MoCA score was not associated with any imaging parameter, and disease severity showed no association independent of LEDD. In the choroid plexus, PD was associated with higher bilateral K trans , higher left-sided NPI, and lower bilateral v p . Conclusion PD was associated with widespread alterations in DCE-MRI-derived permeability measures and fractional plasma volume. Altered choroid plexus contrast kinetics further suggest involvement of the blood-cerebrospinal fluid interface. Exploratory associations with disease duration, LEDD, and motor laterality support the potential clinical relevance of these imaging abnormalities, and require validation in larger longitudinal cohorts.

Authors

Institutions

Publication Details

Journal
Fluids and Barriers of the CNS
Published
2026-10-14
DOI
https://doi.org/10.1186/s12987-026-00890-7
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Blood-brain barrier dysfunction and altered choroid plexus contrast kinetics in Parkinson’s disease

Nurit Omer, Dan Z. Milikovsky, Gadi Maayan Eshed, Rotem Iris Orad et al.
Fluids and Barriers of the CNS
Parkinson's Disease Mechanisms and Treatments
article

Blood-brain barrier dysfunction and altered choroid plexus contrast kinetics in Parkinson’s disease

Nurit Omer, Dan Z. Milikovsky, Gadi Maayan Eshed, Rotem Iris Orad, Aviad Rabinowich, Tamara Shiner, Dafna Ben Bashat, Roy N. Alcalay, Adi Brenner, Nir Giladi, Noa Bregman, Avner Thaler, Sheida Mirloo, Anat Mirelman, Moran Artzi, Lyna Kamintsky, Sapir Fajerzstein
article en

Abstract

Abstract Background Neurovascular dysfunction may contribute to Parkinson’s disease (PD), but the extent and clinical relevance of blood-brain barrier alterations remain uncertain. We investigated regional blood-brain barrier permeability, fractional plasma volume, and choroid plexus contrast kinetics in patients with PD using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Methods In this exploratory cross-sectional study, 14 patients with PD and nine age-matched controls underwent 3-T DCE-MRI. The transfer constant (K trans ), fractional plasma volume (v p ), and normalized permeability index (NPI), a measure sensitive to slow contrast accumulation, were quantified in predefined cortical, subcortical, white matter, midbrain, and choroid plexus regions. Group differences and, within the PD group, associations with disease duration, levodopa equivalent daily dose (LEDD), disease severity, motor symptom laterality and Montreal Cognitive Assessment (MoCA) score were assessed. Results Compared with controls, participants with PD demonstrated higher K trans and NPI and lower v p across multiple regions, including the basal ganglia, thalamus, hippocampus, midbrain, cerebral cortex, and white matter. Voxel-wise analyses supported the regional findings, showing increased permeability predominantly in the frontal cortex and widespread reductions in v p . In exploratory within-PD analyses, longer disease duration was associated with higher NPI, whereas higher levodopa equivalent daily dose was associated with lower v p . In an exploratory analysis of seven patients with unilateral onset, NPI was higher in the hemisphere contralateral to the clinically affected body side. Within the PD group, MoCA score was not associated with any imaging parameter, and disease severity showed no association independent of LEDD. In the choroid plexus, PD was associated with higher bilateral K trans , higher left-sided NPI, and lower bilateral v p . Conclusion PD was associated with widespread alterations in DCE-MRI-derived permeability measures and fractional plasma volume. Altered choroid plexus contrast kinetics further suggest involvement of the blood-cerebrospinal fluid interface. Exploratory associations with disease duration, LEDD, and motor laterality support the potential clinical relevance of these imaging abnormalities, and require validation in larger longitudinal cohorts.

Fluids and Barriers of the CNS
Dalhousie University (CA), Sunnybrook Health Science Centre (CA), Tel Aviv University (IL), University of Toronto (CA), Columbia University Irving Medical Center (US), Tel Aviv Sourasky Medical Center (IL)
Openalex Percentile: Top 14%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.